These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3355003

  • 1. Surfactant-associated proteins in tracheal aspirates of infants with respiratory distress syndrome after surfactant therapy.
    Chida S, Phelps DS, Cordle C, Soll R, Floros J, Taeusch HW.
    Am Rev Respir Dis; 1988 Apr; 137(4):943-7. PubMed ID: 3355003
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Surfactant protein A and saturated phosphatidylcholine in respiratory distress syndrome.
    Moya FR, Montes HF, Thomas VL, Mouzinho AM, Smith JF, Rosenfeld CR.
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1672-7. PubMed ID: 7952631
    [Abstract] [Full Text] [Related]

  • 4. Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid. Correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants.
    Hallman M, Merritt TA, Akino T, Bry K.
    Am Rev Respir Dis; 1991 Dec; 144(6):1376-84. PubMed ID: 1741552
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Surfactant proteins and anti-surfactant antibodies in sera from infants with respiratory distress syndrome with and without surfactant treatment.
    Chida S, Phelps DS, Soll RF, Taeusch HW.
    Pediatrics; 1991 Jul; 88(1):84-9. PubMed ID: 2057277
    [Abstract] [Full Text] [Related]

  • 7. Surfactant proteins and stable microbubbles in tracheal aspirates of infants with respiratory distress syndrome: relation to the degree of respiratory failure and response to exogenous surfactant.
    Chida S, Fujiwara T, Konishi M, Shimada S, Takahashi A.
    Eur J Pediatr; 1997 Feb; 156(2):131-8. PubMed ID: 9039518
    [Abstract] [Full Text] [Related]

  • 8. Expression of the 35kDa and low molecular weight surfactant-associated proteins in the lungs of infants dying with respiratory distress syndrome.
    deMello DE, Phelps DS, Patel G, Floros J, Lagunoff D.
    Am J Pathol; 1989 Jun; 134(6):1285-93. PubMed ID: 2757118
    [Abstract] [Full Text] [Related]

  • 9. Effect of exogenous surfactant therapy on levels of pulmonary surfactant proteins A and D in preterm infants with respiratory distress syndrome.
    Bae YM, Bae CW, Oh MH, Lee SH, Woo KM, Jung KB.
    J Perinat Med; 2009 Jun; 37(5):561-4. PubMed ID: 19492923
    [Abstract] [Full Text] [Related]

  • 10. Improving the prediction of surfactant deficiency in very low-birthweight infants with respiratory distress.
    Harker LC, Merritt TA, Edwards DK.
    J Perinatol; 1992 Jun; 12(2):129-33. PubMed ID: 1522430
    [Abstract] [Full Text] [Related]

  • 11. Repeat surfactant therapy for postsurfactant slump.
    Katz LA, Klein JM.
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of stable microbubble test of tracheal aspirate for the diagnosis of neonatal respiratory distress syndrome.
    Boo NY, Cheong KB, Cheong SK, Lye MS, Zulfiqar MA.
    J Paediatr Child Health; 1997 Aug; 33(4):329-34. PubMed ID: 9323622
    [Abstract] [Full Text] [Related]

  • 13. Inherited disorders of neonatal lung diseases.
    Yurdakök M.
    Turk J Pediatr; 2004 Aug; 46(2):105-14. PubMed ID: 15214737
    [Abstract] [Full Text] [Related]

  • 14. Surfactant apoprotein A (SP-A) in tracheal aspirates of newborn infants with RDS.
    Eguchi H, Koyama N, Tanaka T, Kamiya K, Ogawa Y.
    Acta Paediatr Jpn; 1991 Oct; 33(5):649-54. PubMed ID: 1799120
    [Abstract] [Full Text] [Related]

  • 15. Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome.
    Wang JY, Yeh TF, Lin YC, Miyamura K, Holmskov U, Reid KB.
    Thorax; 1996 Sep; 51(9):907-13. PubMed ID: 8984701
    [Abstract] [Full Text] [Related]

  • 16. Cardiopulmonary bypass reduces pulmonary surfactant activity in infants.
    Griese M, Wilnhammer C, Jansen S, Rinker C.
    J Thorac Cardiovasc Surg; 1999 Aug; 118(2):237-44. PubMed ID: 10424996
    [Abstract] [Full Text] [Related]

  • 17. Does surfactant type cause a differential proinflammatory response in preterm infants with respiratory distress syndrome?
    Mercado VV, Cristea I, Ali N, Pham CC, Buescher E, Yang J, Fisher J, Maramreddy H, Calo J, Strassberg S, Parton LA.
    Adv Ther; 2010 Jul; 27(7):476-82. PubMed ID: 20586001
    [Abstract] [Full Text] [Related]

  • 18. Prenatal dexamethasone and exogenous surfactant therapy: surface activity and surfactant components in airway specimens.
    Kari MA, Akino T, Hallman M.
    Pediatr Res; 1995 Nov; 38(5):676-84. PubMed ID: 8552433
    [Abstract] [Full Text] [Related]

  • 19. Phospholipids in tracheal effluent from infants with severe respiratory distress syndrome.
    Bose CL, Richardson P, Wood B, Gonzalez F, King J.
    Am J Perinatol; 1984 Apr; 1(3):208-13. PubMed ID: 6549258
    [Abstract] [Full Text] [Related]

  • 20. Endogenous surfactant metabolism in newborn infants with and without respiratory failure.
    Bohlin K, Merchak A, Spence K, Patterson BW, Hamvas A.
    Pediatr Res; 2003 Aug; 54(2):185-91. PubMed ID: 12736380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.